Remove MRI Remove PET Scan Remove Radiopharmaceuticals
article thumbnail

Meet the Minnies 2024 semifinal candidates

AuntMinnie

tesla MRI AI body composition analysis Cardiac PET Cryo/thermoablation CT colonography Genicular artery embolization Hyperpolarized xenon-129 MRI PET/MRI Photon-counting CT Radiomics Theranostics Whole-body MRI screening Image of the Year 3D PET/MR image. tesla brain MRI scans.

article thumbnail

Unlocking the potential of imaging in Alzheimer’s disease care

AuntMinnie

Reimbursement barriers Unfortunately, until recently, there were significant barriers to receiving amyloid PET imaging in some regions. Centers for Medicare and Medicaid Services (CMS), for example, did not cover amyloid PET scans outside of clinical trials for Medicare beneficiaries and only covered one scan per patient’s lifetime.

Disease 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

U.S. FDA Approves Blue Earth Diagnostics’ POSLUMA (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

Imaging Technology

milla1cf Tue, 05/30/2023 - 19:49 May 30, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals , today announced U.S. Results demonstrated high detection rates (% positive PET scans) even at low PSA levels.

article thumbnail

Road to RSNA 2024: Molecular Imaging Preview

AuntMinnie

All studies in the sole slated session on novel radiopharmaceuticals this year are on FAPI-PET tracers. There’s plenty of other exciting research, including new findings using PET/CT in women with breast cancer and one study suggesting PET/MRI can diagnose myocardial injury in long COVID patients. 8:40 a.m. |

Imaging 264